产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
猜你想搜
首页 制药产品大全 原料药 司美格鲁肽

司美格鲁肽

2026-10-31
1169630-82-3
中国药典,企业标准
药用级

产品详情

司美格鲁肽
其他西药原料
1169630-82-3
中国药典,企业标准
药用级
司美格鲁肽/=Wagovy
否
中国,北美洲,东欧,中东
是

产品描述

Semaglutide is a new 2nd Generation GLP-1RA drug developed by Novo Nordisk. In Dec. 2019, Semaglutide injection (brand name: Ozempic, 4mg/3ml) was approved by FDA to improve glycemic control in adults with type 2 diabetes. In Jun. 2021, Semaglutide injection (brand name: Wegovy, 2.4mg/dose) was approved by FDA to treat obesity (BMI≥30kg/m2) and overweight (BMI≥27kg/m2). In Sep. 2019, oral Semaglutide (brand name: Rybelsus, 3mg, 7mg and 14mg/ tablet) was approved by FDA for the treatment of type 2 diabetes. Meanwhile, Rybelsus 25mg and 50mg strengths showed clear effects in Phase II and Phase III clinical trials for weight loss or non-alcoholic fatty liver (NASH). Semaglutide is composed of 31 amino acids and has 94% homology with human GLP-1 (7-37) [Aib replaces Ala at position 8, and Arg replaces Lys at position 34]. In the production of the original drug, the 29-peptide intermediate is fermented by yeast recombinant expression, after which the Lys at position 26 is modified by stearic acid (C18). Then the modified product goes through condensation reaction with His-Aib dipeptide containing protecting group, followed by purification and lyophilization to obtain the Semaglutide drug substance (API). Peg-Bio’s Semaglutide intermediate (P29, also GLP-1 K34R (9-37)) is a 29 amino acid peptide developed via TE-PEP® recombinant E. coli expression. (TE-PEP® is one of Peg-Bio’s proprietary technology platforms, featuring high efficiency and high-density tandem expression of peptides.) The molecular structure of P29 is C142H216N38O45 and its CAS no. is 1169630-82-3, with a molecular weight of 3175.50 Da. Through fatty acid chain modification and condensation reaction with His-Aib dipeptide, P29 can be used to produce Semaglutide API – and the process route is consistent with that of the original drug’s semi-synthetic processes.

苏州法默赛科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

以“关爱生命、健康至上、可负担的API”为使命,我们希望与您携手合作,实现共赢,共同促进健康生活。 我司主要产品包括 司美格鲁肽、替尔泊肽、利拉鲁肽、依替巴肽、加尼瑞克、醋酸格拉替雷、特利加压素乙酸盐、奥曲肽乙酸盐、催产素乙酸盐、去氨加压素、亮丙瑞林、醋酸西曲瑞克、醋酸卡贝缩宫素、醋酸阿托西班、利那洛肽。
业务类型:
成立日期:
年营业额:
主营产品类别: